Skip to content

Comparison of oral paracetamol versus combined oral paracetamol and sponging with water for control of fever in 5-10 year children

Efficacy of Combined Tepid sponging with oral paracetamol versus Oral paracetamol in reduction of fever among children of 5 â?? 10 years of age â?? a Randomized Control Trial. - TSAPP Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/09/021437
Enrollment
106
Registered
2019-09-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B999- Unspecified infectious disease

Interventions

Intervention1: Combined Tepid sponging with oral paracetamol: Intervention group will receive tepid sponging and syrup paracetamol (15mg/kg) for management of fever Control Intervention1: oral paracet

Sponsors

Dr Vijay Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients between 5yrs and 10 yrs admitted to children ward with fever (axillary temperature >100 F) in the first 24 hrs of admission.

Exclusion criteria

Exclusion criteria: 1. Any critically ill patient requiring inotropes or oxygen support 2. Patient with shock 3. Patients with MODS (multi organ dysfunction syndrome) 4. Not able to tolerate oral medicines 5. GI Bleed 6. Convulsion 7. Received fever medication in last 6 hrs

Design outcomes

Primary

MeasureTime frame
1.To evaluate the efficacy of combined Tepid Sponging with oral Paracetamol versus oral Paracetamol in the reduction of fever among Children of 5-10 years of age at 1 hr Timepoint: 1 hour from enrollment

Secondary

MeasureTime frame
1.To evaluate the efficacy of combined Tepid Sponging with oral Paracetamol versus oral Paracetamol in the reduction of fever among Children of 5-10 years of age at different time points (30 minutes, 2 hrs, 4 hr, 8 hr, 12hr, 16hr, 20 hr and 24 hr) 2.To evaluate the two methods in terms of patient comfort and compliance 3.To evaluate the side effects or discomfort levels in the two arms 4.To evaluate the cumulative amount of antipyretic used in the two arms in the first 24 hrsTimepoint: 24 hrs from enrollment

Countries

India

Contacts

Public ContactVijay Gupta

Gajra Raja Medical College Gwalior

yzaygupta@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026